reaching – Lab DB

Pharmaceutical R&D

The Non-GLP-1 Obesity Drug Market Set for Explosive 50-Fold Growth, Reaching $15.5 Billion by 2031

Teuku Ryan Apr 21, 2026 0

The global pharmaceutical market for obesity treatments is poised for a dramatic transformation, with a burgeoning segment of non-Glucagon-like peptide-1…

The Non-GLP-1 Obesity Drug Market Set for Explosive 50-Fold Growth, Reaching $15.5 Billion by 2031

YOU MAY HAVE MISSED

Optimizing spaCy for Production-Grade NLP: Advanced Techniques for Speed and Accuracy

Forests’ Ancient Carbon Cycle Disrupted by Pervasive Nitrogen Pollution, New Study Reveals

TWiV 1292: Clinical update with Dr. Daniel Griffin

Cornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis